BioXcel Therapeutics News - BTAI

Company Name	Stock Ticker Symbol	Market	Type
BioXcel Therapeutics Inc	BTAI	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.04	1.48%	2.75	06:01:44

Open Price	Low Price	High Price	Close Price	Prev Close
				2.71

more quote information »

Recent News

Date	Time	Source	Heading
4/24/2024	10:30	GLOBE	BioXcel Therapeutics Announces Late-Breaking Abstract on..
4/22/2024	07:00	GLOBE	BioXcel Therapeutics Announces Plan for Evaluating BXCL501..
4/10/2024	07:00	GLOBE	BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal..
3/25/2024	07:00	GLOBE	BioXcel Therapeutics Announces $25 Million Registered Direct..
3/15/2024	07:00	GLOBE	BioXcel Therapeutics Announces European Patent Office’s..
3/12/2024	07:00	GLOBE	BioXcel Therapeutics Reports Financial Results for the..
3/01/2024	07:00	GLOBE	BioXcel Therapeutics to Report Fourth Quarter and Full Year..
2/14/2024	07:00	EDGAR2	Form 8-K - Current report
2/13/2024	09:00	GLOBE	BioXcel Therapeutics Announces Termination of Proposed..
2/12/2024	12:45	EDGAR2	Form 8-K - Current report
2/12/2024	07:14	GLOBE	BioXcel Therapeutics Receives FDA Fast Track Designation for..
2/08/2024	17:27	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/08/2024	16:53	EDGAR2	Form 8-K - Current report
2/08/2024	16:01	GLOBE	BioXcel Therapeutics Announces Proposed Public Offering
2/08/2024	07:08	EDGAR2	Form 8-K - Current report
2/06/2024	07:00	GLOBE	BioXcel Therapeutics Announces Completion of Patient..
2/05/2024	07:00	GLOBE	BioXcel Therapeutics Announces USPTO’s Allowance of Patent..
1/23/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/12/2024	16:16	EDGAR2	Form S-3 - Registration statement under Securities Act of..
12/18/2023	16:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/18/2023	16:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/18/2023	16:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/18/2023	07:22	EDGAR2	Form 8-K - Current report
12/12/2023	07:00	EDGAR2	Form 8-K - Current report
12/12/2023	07:00	GLOBE	BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day..
12/11/2023	07:00	GLOBE	BioXcel Therapeutics Strengthens Clinical Development..
12/06/2023	07:00	EDGAR2	Form 8-K - Current report
11/30/2023	07:00	GLOBE	BioXcel Therapeutics to Host Virtual Neuroscience R&D Day on..
11/13/2023	11:59	EDGAR2	Form RW WD - Withdrawal of Registration Withdrawal Request
11/13/2023	10:23	EDGAR2	Form RW - Registration Withdrawal Request
11/08/2023	07:00	GLOBE	BioXcel Therapeutics Reports Positive Overall Survival..
11/06/2023	07:00	GLOBE	BioXcel Therapeutics Announces Update on NIDA-funded Trial..
11/02/2023	06:01	EDGAR2	Form S-3 - Registration statement under Securities Act of..
10/31/2023	07:00	GLOBE	BioXcel Therapeutics to Report Third Quarter 2023 Financial..
10/30/2023	07:00	GLOBE	BioXcel Therapeutics Receives Permanent J-Code for IGALMI™..
10/25/2023	10:30	APS	Strong Open For Biotech Shares Following Phase 3 Comments
10/25/2023	07:00	GLOBE	BioXcel Therapeutics Announces Positive Findings from..
10/19/2023	16:48	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
10/10/2023	07:06	EDGAR2	Form 8-K - Current report
10/10/2023	07:00	GLOBE	BioXcel Therapeutics Reports Positive Overall Survival..
10/04/2023	07:05	EDGAR2	Form 8-K - Current report
10/04/2023	07:00	GLOBE	BioXcel Therapeutics Provides Update on Recent Developments..
9/25/2023	17:07	EDGAR2	Form 8-K - Current report
9/20/2023	11:21	EDGAR2	Form 144 - Report of proposed sale of securities
9/20/2023	11:15	EDGAR2	Form 144 - Report of proposed sale of securities
9/19/2023	08:00	EDGAR2	Form 8-K - Current report
9/18/2023	16:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/18/2023	16:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/18/2023	16:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/12/2023	07:00	EDGAR2	Form 8-K - Current report